Last updated date
ABOUT THIS STUDY
The objective of this Surveillance is to verify the following subject matters concerning Tofacitinib (Xeljanz) under general practice. 1) Occurrence of adverse reactions, factors that may potentially affect safety and efficacy 2） Long-term safety (particularly, malignant tumors and serious infections) and efficacy Occurrences of malignant tumors and serious infections will be compared with a control group.
Females and Males
- All patients receiving Tofacitinib (Xeljanz)
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Rheumatoid ArthritisCONfident Treatment Decisions in Living With Rheumatoid Arthritis
- Birmingham, Alabama
Rheumatoid ArthritisEffect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells
Rheumatoid ArthritisRheumatoid Arthritis DMARD Intervention and UtilizationStudy
Rheumatoid ArthritisEffects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project